Alkem Laboratories Q3 net profit down 23 percent at Rs 181 crore
New Delhi: Alkem Laboratories reported a 23.44 percent decline in its consolidated net profit at Rs 180.87 crore for the quarter ended December 2017 on higher tax expenses.
The company had posted a net profit of Rs 236.26 crore during the same period of the previous fiscal, Alkem Laboratories said in a regulatory filing.
Total income during the quarter under review stood at Rs 1,765.05 crore. It was Rs 1,507.32 crore in the corresponding quarter last fiscal.
"Amidst challenging regulatory environment and competitive landscape, we have not only achieved robust revenue growth but have also complimented it with improvement in our profit margins," Alkem Laboratories Managing Director Sandeep Singh said.
The company declared an interim dividend of Rs 6 per equity share on face value of Rs 2 per share for the financial year 2017-18.
It said the revenue R&D expenses for the quarter were Rs 92.7 crore, or 5.3 percent, of total revenue from operations.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd